As of November 2024, Dawnrays Pharmaceutical has a market cap of $211.68M. This makes Dawnrays Pharmaceutical the world's 16984th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $217.46M | 7.62% |
2023 | $202.06M | -21.05% |
2022 | $255.95M | -20.36% |
2021 | $321.38M | 20.14% |
2020 | $267.49M | -2.80% |
2019 | $275.19M | -2.72% |
2018 | $282.89M | -31.15% |
2017 | $410.86M | -8.37% |
2016 | $448.39M | -22.59% |
2015 | $579.25M | 21.62% |
2014 | $476.29M | 0.41% |
2013 | $474.37M | 220.13% |
2012 | $148.18M | -31.56% |
2011 | $216.50M | -38.36% |
2010 | $351.20M | 192.00% |
2009 | $120.28M | 78.57% |
2008 | $67.35M | -12.50% |
2007 | $76.98M | 1.27% |
2006 | $76.01M | 27.42% |
2005 | $59.66M | -1.59% |
2004 | $60.62M | -21.25% |
2003 | $76.98M | - |